Trial intelligence / Profile preview

Sodium bicarbonate Ringer's solution vs Ringer's acetate in goal-directed fluid therapy for liver transplantation

ChiCTR2100050486Phase 4Recruiting

Sponsor
The Third Hospital of Hebei Medical University
Start
Jan 2021
Modality
Small Molecules, Implantable Devices → Device-based Delivery → Drug Delivery Systems, Transdermal Patches → Device-based Delivery → Drug Delivery Systems
Countries
1
01

Overview

Phase 4 trial of sodium bicarbonate ringer's solution in hepatic disease and hepatocellular carcinoma (HCC) (2 arms), sponsored by The Third Hospital of Hebei Medical University. Primary endpoint: Intraoperative 5% sodium bicarbonate usage. Started Jan 2021; status: recruiting.

02

Drugs

sodium bicarbonate ringer's solution
03

Conditions

hepatic diseasehepatocellular carcinoma (HCC)

Beyond the preview

Go deeper on ChiCTR2100050486.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2100050486.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call